AJP - Endo Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 283: E20-E28, 2002. First published February 26, 2002; doi:10.1152/ajpendo.00294.2001
0193-1849/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/1/E20    most recent
00294.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blomqvist, G.
Right arrow Articles by Ekberg, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blomqvist, G.
Right arrow Articles by Ekberg, K.
Vol. 283, Issue 1, E20-E28, July 2002

Effect of acute hyperketonemia on the cerebral uptake of ketone bodies in nondiabetic subjects and IDDM patients

G. Blomqvist1, M. Alvarsson2, V. Grill2,3, G. Von Heijne4, M. Ingvar4, J. O. Thorell5, S. Stone-Elander5, L. Widén4, and K. Ekberg6

1 Uppsala University PET Centre, University Hospital Uppsala, S-75185 Uppsala; Departments of 2 Endocrinology and Physiology, 4 Clinical Neuroscience, and 6 Clinical Physiology, and 5 Karolinska Pharmacy, Karolinska Hospital, S-17176 Stockholm; and 3 Section Endocrinology, Department of Medicine, University Hospital of Trondheim, N-7006, Norway

Using R-beta -[1-11C]hydroxybutyrate and positron emission tomography, we studied the effect of acute hyperketonemia (range 0.7-1.7 µmol/ml) on cerebral ketone body utilization in six nondiabetic subjects and six insulin-dependent diabetes mellitus (IDDM) patients with average metabolic control (HbA1c = 8.1 ± 1.7%). An infusion of unlabeled R-beta -hydroxybutyrate was started 1 h before the bolus injection of R-beta -[1-11C]hydroxybutyrate. The time course of the radioactivity in the brain was measured during 10 min. For both groups, the utilization rate of ketone bodies was found to increase nearly proportionally with the plasma concentration of ketone bodies (1.0 ± 0.3 µmol/ml for nondiabetic subjects and 1.3 ± 0.3 µmol/ml for IDDM patients). No transport of ketone bodies from the brain could be detected. This result, together with a recent study of the tissue concentration of R-beta -hydroxybutyrate in the brain by magnetic resonance spectroscopy, indicate that, also at acute hyperketonemia, the rate-limiting step for ketone body utilization is the transport into the brain. No significant difference in transport and utilization of ketone bodies could be detected between the nondiabetic subjects and the IDDM patients.

beta -hydroxybutyrate; blood-brain barrier; positron emission tomography


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. Bentourkia, S. Tremblay, F. Pifferi, J. Rousseau, R. Lecomte, and S. Cunnane
PET study of 11C-acetoacetate kinetics in rat brain during dietary treatments affecting ketosis
Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E796 - E801.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
S. L. Wootton-Gorges, M. H. Buonocore, N. Kuppermann, J. Marcin, J. DiCarlo, E. K. Neely, P. D. Barnes, and N. Glaser
Detection of Cerebral {beta}-Hydroxy Butyrate, Acetoacetate, and Lactate on Proton MR Spectroscopy in Children with Diabetic Ketoacidosis
AJNR Am. J. Neuroradiol., May 1, 2005; 26(5): 1286 - 1291.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online